Related Experiment Video
Updated: Feb 24, 2026

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
Constipation in adults with neurofibromatosis type 1
Cecilie Ejerskov1,2,3, Klaus Krogh4, John R Ostergaard5
1Centre for Rare Diseases, Pediatrics and Adolescent Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark. CECILIE@EJERSKOV.DK.
Adults with Neurofibromatosis type 1 (NF1) experience more gastrointestinal issues, particularly functional constipation, compared to relatives without the condition. This suggests constipation is a direct symptom of NF1.
Area of Science:
- Gastroenterology
- Genetics
- Clinical Medicine
Background:
- Neurofibromatosis type 1 (NF1) is an autosomal-dominant disorder affecting multiple systems.
- Previous research noted gastrointestinal issues like constipation in children with NF1.
- This study focuses on gastrointestinal symptoms in adult NF1 patients.
Purpose of the Study:
- To compare the prevalence of gastrointestinal symptoms in adult NF1 patients versus unaffected relatives.
- To identify specific functional gastrointestinal disorders more common in NF1 patients.
Main Methods:
- Adult NF1 patients and their unaffected relatives were recruited.
- A validated Rome III questionnaire assessed gastrointestinal symptoms via a web-based survey.
- Logistic regression analysis was used to compare symptom prevalence and odds ratios.
Main Results:
- The overall prevalence of functional constipation, irritable bowel syndrome (IBS), or functional dyspepsia was significantly higher in NF1 patients (33.1%) than controls (14.3%).
- NF1 patients had a markedly higher likelihood of functional constipation (OR: 3.49) and a slightly higher likelihood of IBS (OR: 2.46) after adjustment.
- No significant difference in functional dyspepsia was observed between groups.
Conclusions:
- Gastrointestinal symptoms, especially constipation, are more prevalent in adults with NF1 compared to controls.
- The high prevalence of constipation in NF1 suggests it is an intrinsic part of the disorder, not merely functional.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Irritable Bowel Syndrome III: Medical and Nursing Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

